Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.290
+0.050 (2.23%)
At close: Dec 20, 2024, 4:00 PM
2.330
+0.040 (1.75%)
After-hours: Dec 20, 2024, 6:32 PM EST
Autolus Therapeutics Employees
As of December 31, 2023, Autolus Therapeutics had 471 total employees, including 463 full-time and 8 part-time employees. The number of employees increased by 67 or 16.58% compared to the previous year.
Employees
471
Change (1Y)
67
Growth (1Y)
16.58%
Revenue / Employee
$21,425
Profits / Employee
-$573,730
Market Cap
609.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cross Country Healthcare | 13,131 |
Varex Imaging | 2,300 |
Pharming Group | 382 |
Ironwood Pharmaceuticals | 267 |
Omeros | 198 |
Entrada Therapeutics | 159 |
Stoke Therapeutics | 110 |
Capricor Therapeutics | 102 |
AUTL News
- 11 days ago - Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 - GlobeNewsWire
- 4 weeks ago - AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market - Seeking Alpha
- 5 weeks ago - Autolus Therapeutics plc (AUTL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) - GlobeNewsWire
- 7 weeks ago - Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - GlobeNewsWire
- 3 months ago - Autolus: Start Thinking About Obe-Cel PDUFA -- And The (Baby) Bull Case - Seeking Alpha
- 4 months ago - Autolus Therapeutics plc (AUTL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 - GlobeNewsWire